Losonczy Attila, Somogyi Peter, Nusser Zoltan
Laboratory of Cellular Neurophysiology, Institute of Experimental Medicine, 1083 Budapest, Hungary; and Medical Research Council, Anatomical Neuropharmacology Unit, University Department of Pharmacology, Oxford OX1 3TH, United Kingdom.
J Neurophysiol. 2003 Apr;89(4):1910-9. doi: 10.1152/jn.00842.2002.
The release of glutamate from axon terminals is under the control of a variety of presynaptic receptors, including several metabotropic glutamate receptors (mGluRs). Synaptically released glutamate can activate mGluRs within the same synapse where it was released and also at a distance following its diffusion from the synaptic cleft. It is unknown, however, whether the release of glutamate is under the control of persistently active mGluRs. We tested the contribution of mGluR activation to the excitatory postsynaptic responses recorded from several types of GABAergic interneuron in strata oriens/alveus of the mouse hippocampus. The application of 1 microM (alphaS)-alpha-amino-alpha-[(1S,2S)-2-carboxycyclopropyl]xanthine-9-propanoic acid (LY341495), a broad-spectrum mGluR (subtypes 2/3/7/8) antagonist at this concentration, increased evoked-excitatory postsynaptic current (eEPSC) amplitudes by 60% (n = 33). On identified cell types, LY341495 had either no effect (7 of 14 basket and 7 of 13 oriens-lacunosum moleculare, O-LM cells) or resulted in a 32 +/- 30% (mean +/- SD) increase in EPSC amplitudes recorded from basket cells and a seven-times greater (216 +/- 102%) enhancement of EPSCs in O-LM cells. The enhancement of the first EPSC of a high-frequency train indicates persistent mGluR activation. During antagonist application, the relative increase in EPSC amplitude evoked by the second and subsequent pulses in the train was not larger than that of the first EPSC, showing no further receptor activation by the released transmitter. The effect of mGluR subtype selective agonists [3 microM L(+)-2-amino-4-phosphonobutyric acid (L-AP4): mGluR4/8; 600 microM L-AP4: mGluR4/7/8; 1 microM (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IU): mGluR2/3] and an antagonist (0.2 microM LY341495: mGluR2/3/8) suggests that persistently active mGluR2/3/8 control the excitability of hippocampal network.
轴突终末释放谷氨酸受多种突触前受体的调控,包括几种代谢型谷氨酸受体(mGluRs)。突触释放的谷氨酸可激活其释放部位同一突触内的mGluRs,也可在从突触间隙扩散后在一定距离处激活。然而,谷氨酸的释放是否受持续激活的mGluRs的控制尚不清楚。我们测试了mGluR激活对从小鼠海马体的内嗅层/肺泡层几种类型的GABA能中间神经元记录的兴奋性突触后反应的影响。在此浓度下,应用1 microM(αS)-α-氨基-α-[(1S,2S)-2-羧基环丙基]黄嘌呤-9-丙酸(LY341495),一种广谱mGluR(2/3/7/8亚型)拮抗剂,可使诱发的兴奋性突触后电流(eEPSC)幅度增加60%(n = 33)。在已鉴定的细胞类型上,LY341495要么没有作用(14个篮状细胞中的7个和13个分子层空泡内嗅层细胞中的7个,即O-LM细胞),要么导致从篮状细胞记录的EPSC幅度增加32±30%(平均值±标准差),而在O-LM细胞中EPSC增强了7倍(216±102%)。高频串刺激中第一个EPSC的增强表明mGluR持续激活。在应用拮抗剂期间,串刺激中第二个及后续脉冲诱发的EPSC幅度的相对增加不大于第一个EPSC,表明释放的递质没有进一步激活受体。mGluR亚型选择性激动剂[3 microM L(+)-2-氨基-4-膦酰丁酸(L-AP4):mGluR4/8;600 microM L-AP4:mGluR4/7/8;1 microM(2S,2'R,3'R)-2-(2',3'-二羧基环丙基)甘氨酸(DCG-IU):mGluR2/3]和一种拮抗剂(0.2 microM LY341495:mGluR2/3/8)的作用表明,持续激活的mGluR2/3/8控制着海马体网络的兴奋性。